1INTRODUCTIONMelanoma is an aggressive malignancy associated with significant clinical, biological and epidemiological heterogeneity. It affects Caucasian populations more commonly than peoples with pigmented skin, including Asians. Data from the National Cancer Institute Surveillance, Epidemiology and End Results Program (SEER) revealed an age‐adjusted incidence of 21.9 persons per 100 000 population per year in non‐Hispanic “whites,” as opposed to < 5 per 100 000 for all other ethnicities; the incidence in Asians was 1.5 per 100 000. In spite of these ethnogeographic disparities in incidence, advanced melanoma has a universally poor prognosis, with 5‐year survival in metastatic disease at 10–15%.The modern taxonomy of melanocytic neoplasia derives from a seminal publication by Curtin and colleagues who established four clinically defined categories that are genetically distinct. The first two categories are cutaneous melanomas (CMs) developing in sun‐exposed skin that are distinguished by the extent of cumulative sun damage (CSD), defined by the degree of associated solar elastosis. Melanomas with evidence of extensive damage are termed CSD melanomas, while those with evidence of minimal damage are called non‐CSD melanomas. The other two categories arise in relatively sun‐protected anatomic sites – acral melanomas (AMs) refer to disease affecting the nail‐beds and glabrous skin of palms and soles, while mucosal
Asia-Pacific Journal of Clinical Oncology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera